MedPath

MVRx, Inc.

MVRx, Inc. logo
🇺🇸United States
Ownership
Private
Established
2009-01-01
Employees
11
Market Cap
-
Website
http://www.mvrxinc.com

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

MitrAl ValvE RepaIr Clinical Trial (MAVERIC Trial) - United States

Not Applicable
Terminated
Conditions
Mitral Valve Insufficiency
First Posted Date
2017-10-17
Last Posted Date
2021-04-28
Lead Sponsor
Mvrx, Inc.
Target Recruit Count
1
Registration Number
NCT03311295
Locations
🇺🇸

UC Davis Medical Center, Sacramento, California, United States

Treatment of Heart Failure and Associated Functional Mitral Valve Regurgitation

Not Applicable
Conditions
Mitral Valve Regurgitation
First Posted Date
2014-11-27
Last Posted Date
2021-04-28
Lead Sponsor
Mvrx, Inc.
Target Recruit Count
51
Registration Number
NCT02302872
Locations
🇦🇺

The Wesley Hospital, Auchenflower, Queensland, Australia

🇦🇺

St Andrews Hospital, Adelaide, South Australia, Australia

🇦🇺

Warringal Private Hospital, Heidelberg, Australia

and more 6 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.